Compugen LTD balance sheet
At the end of fiscal 2025, Compugen LTD had total assets of $157m and shareholders' equity of $103m. It held $90.6m in cash against $0 of debt: net cash of $90.6m.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2018Dec 2018 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 15 | 7 | 16 | 29 | 26 | 11 | 10 | 6 | 7 | 8 | 11 | 14 | 18 | 91 |
| Receivables | — | 0 | — | — | — | 8 | — | — | 2 | — | 0 | 61 | 0 | — |
| Total current assets | — | 28 | 26 | 53 | 75 | 91 | 63 | 47 | 129 | 123 | 86 | 115 | 106 | 148 |
| Total assets | — | 36 | 29 | 57 | 115 | 99 | 71 | 53 | 138 | 132 | 94 | 121 | 115 | 157 |
| Accounts payable | — | 1 | 0 | 1 | 1 | 2 | 1 | 3 | 1 | 5 | 2 | 4 | 2 | 2 |
| Deferred revenue (current) | — | — | — | 5 | 2 | 0 | — | — | — | — | 0 | 11 | 10 | 11 |
| Total current liabilities | — | 2 | 1 | 8 | 7 | 7 | 5 | 10 | 11 | 17 | 12 | 26 | 20 | 23 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' equity | 27 | 28 | 18 | 32 | 106 | 90 | 64 | 37 | 120 | 107 | 78 | 66 | 55 | 103 |
| Net debt (negative = net cash) | −15 | −7 | −16 | −29 | −26 | −11 | −10 | −6 | −7 | −8 | −11 | −14 | −18 | −91 |
| Shares outstanding | 33m | 34m | 37m | 41m | 50m | 51m | 51m | 60m | 84m | 86m | 87m | 89m | 90m | 95m |
Compare with peers
- Viridian Therapeutics, Inc.\de balance sheet
- Wave Life Sciences, Inc. balance sheet
- Assembly Biosciences, Inc. balance sheet
- Recursion Pharmaceuticals, Inc. balance sheet
- Cytokinetics Inc balance sheet
Head to head: CGEN vs VRDNCGEN vs WVEASMB vs CGEN
More: Biotechnology stocks compared, Health Care sector, rankings of US companies